about
The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective studyProtein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin.Management of uterine leiomyomas in pregnancy: review of literature.Oxytocin plasma levels in orgasmic and anorgasmic women.Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia.Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.Effects of corticotropin-releasing hormone on ovarian estrogen production in vitro.Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome.Clitoral blood flow changes after surgery for stress urinary incontinence: pilot study on TVT Versus TOT procedures.Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate.[Low dose oral contraceptives: 30 microg are still used?]Unexplained sterility: diagnosis and therapy.Quality of sexual life of women using the contraceptive vaginal ring in extended cycles: preliminary report.Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives.Early clamping of umbilical cord blood and foetal CD34 enrichment.Role of DEXA and ultrasonometry in the evaluation of osteoporotic risk in postmenopausal women.Comparison of dexa and ultrasonometry in the measurement of bone density.Uterine bleeding pattern during low dosage Noretisterone acetate and 17-b-Estradiol treatment in postmenopausal patients.Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene.[From cervico-vaginitis to PID: therapeutic prospects]Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder.Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study.Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women.Ultrastructural and quantitative study of clitoral cavernous tissue from living subjects.Altered transcriptional regulation of cytokines, growth factors, and apoptotic proteins in the endometrium of infertile women with chronic endometritis.Hyperandrogenic women treated with a continuous-regimen oral contraceptive.Prospective study evaluating olfactometric and rhinomanometric outcomes in postmenopausal women on 1 mg 17beta-estradiol and 2 mg drospirenone HT.Prospective study on sexual behavior of women using 30 microg ethinylestradiol and 3 mg drospirenone oral contraceptive.Prospective study on the cytological aspects of the nasal respiratory epithelium in premenopausal women taking 30 mcg ethinylestradiol and 3 mg drospirenone oral contraceptive.Characteristics of nasal epithelial cells in naturally postmenopausal women receiving hormone therapy with 1 mg 17beta-estradiol and 2 mg drospirenone: a prospective study.Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?Randomized crossover study investigating daily versus on-demand vulvar Visnadine spray in women affected by female sexual arousal disorder.Effects of Urinary Incontinence Subtypes on Women's Sexual Function and Quality of Life.Neurovegetative disorders of perimenopausal women treated with docosahexaenoic acid (DHA, 625 mg).Efficacy, tolerability and safety of a new medical device, Monurelle Biogel(®) vaginal gel, in the treatment of vaginal dryness: a randomized clinical trial in women of reproductive age.Chronic pelvic pain, quality of life and sexual health of women treated with palmitoylethanolamide and α-lipoic acid.Quality of sexual life of women on oral contraceptive continued-regimen: pilot study.Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women.Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
P50
Q28248914-DD4DE8DF-CCC7-4BE6-A5CD-8FFED09EB469Q34226362-BD15876C-CA6C-4E46-94D1-6A4F9E664309Q38077663-AE2AEE22-FDB3-496D-A4D6-9863C7BE6EFFQ40163895-6A5E8595-096C-49C7-BA06-5A16873CC22CQ42481258-89C6B7A3-A3B8-4407-8B33-BC924BA55F76Q42510818-A965A843-5C48-439E-8139-6B326DA33D70Q42523979-1C6DE8A1-7810-4449-96A3-533AFE45D8FDQ42528609-2F92B44C-7DAA-454F-A512-80951B4A4D9BQ42632975-E5365806-9306-4C3F-9BC2-C36F29B3760FQ42939339-B740B2EA-572D-46D2-B509-11D027B6FF79Q43260764-2F1784A7-C8B9-4A74-B39B-68A28A5B1A31Q43277286-EDF45779-FB1C-4019-81D3-FC78EAFF9226Q43518460-01305FC8-42A2-4695-85B2-FA238093EC78Q43521079-A3B8EC7F-B6D0-4940-9FD3-1F462CA924EDQ43796274-36CDB1FC-2339-46A4-ACB6-894308EEA45CQ43844276-04772C1D-C13A-4055-95E1-A8A9D50B2C29Q44028316-5E83D9B0-00AD-4154-B7CC-EA853FACE789Q44115634-BEFFDC49-D438-4357-95D1-CA7984B69DC7Q44216839-153D5C88-4409-4592-9157-BB51AD187ACCQ44768186-81AE5FA0-180A-4749-840F-7AB1D6B01E4FQ44836270-87EC0B43-EDB4-4F02-B0EF-5E12A363B80EQ44889727-8DFC1377-2FD4-4388-A705-A8C0BF8DC26CQ44958364-0799A034-351B-4EF6-8AD3-001F82D489A2Q45006995-28FFC0E7-5AEF-4D39-A1EF-2C313F674654Q45349337-0F6E432E-DAE4-4F97-ACC5-DB1426B6B4E9Q45378202-4FFD7BD1-425A-4D3B-B769-84ABA462B704Q46111085-9A669560-B0C4-4AFC-8E1A-01AE95DB4AC7Q46542366-8821E6B3-FDFF-4082-A5F6-0A43123B308AQ46554140-FF54F119-6253-4FAB-9009-A0EA8FA4CA6FQ46652221-E9B85586-19C8-4F02-AE25-C280958559E0Q46662073-88A486F9-4AC9-45C4-B6D1-5646A5197DA9Q47552229-DD7CA84C-379C-4761-B72B-4BCD4049A9B3Q47685218-43518CA7-C62F-437F-89E0-710DC60A485FQ47718108-2879701D-5EE5-4716-BF1D-3E42E28A1828Q47747061-94A4D7E5-8263-4DDD-96E9-E37EBCBCBE87Q47778653-87B4F060-C98E-458E-A42D-873A7910E14BQ47932357-6F14A330-250A-4672-A932-77709E6B9080Q48351048-06C7D5C9-42E3-4E6C-9D0D-7D2D2CB92286Q48486547-62B0DDEA-A6A8-400E-9158-0A03107DF6D6Q48618652-E33C5D0E-AC3D-4A95-8FD3-1E4F53E37A80
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonio Cianci
@ast
Antonio Cianci
@en
Antonio Cianci
@es
Antonio Cianci
@nl
type
label
Antonio Cianci
@ast
Antonio Cianci
@en
Antonio Cianci
@es
Antonio Cianci
@nl
prefLabel
Antonio Cianci
@ast
Antonio Cianci
@en
Antonio Cianci
@es
Antonio Cianci
@nl
P106
P21
P31
P496
0000-0003-2758-3413